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a b s t r a c t
Dehydrobutyrine is an amino acid that is present in a range of peptide natural products. Reaction of
pentaﬂuoropyridine with threonine and subsequent E1cb-type elimination allowed the preparation of
novel dehydrobutyrine-containing amino acids under mild conditions.
 2014 The Authors. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Dehydroamino acids such as dehydroalanine (Dha, 1) and
dehydrobutyrines (Dhb, 2a and 2b) are naturally occurring amino
acids that are present in a range of peptides1 including antimicro-
bial peptides of the lantibiotic family.2 In lantibiotics such as nisin
A, dehydroalanine (1) and dehydrobutyrine (2a and 2b) react via
Michael addition with cysteine residues to form lanthionine and
methyl lanthionine thio-ether bridges, respectively.2d In nature the
site-speciﬁc introduction of (1) and (2) into peptide chains arises
due to enzymatic post-translational modiﬁcations, in which either
serine or threonine residues are dehydrated by phosphorylation
followed by b-elimination.3 Recently, dehydroamino acids have
also served to provide synthetic handles, enabling a highly useful
route for tagging both short peptides and proteins.4 The formation
of dehydrolanine (1) can be readily achieved from cysteine both as
the free amino acid5 and within larger protein structures via a va-
riety of reaction conditions.4b,6 The synthesis of both dehy-
drobutyrine isomers (2a and 2b) is possible from threonine using
a range of reaction conditions.7 Often the formation of 2a or 2b
from threonine requires harsh reaction conditions, and generally
involves electron-withdrawing substituents, e.g., Boc or nosyl, at
the amino group of the amino acid to increase the acidity of the a-
H.8 Dehydrobutyrines can also be stereospeciﬁcally prepared by
oxidative elimination of phenyl-selenocysteines. However, this re-
quires several synthetic transformations from commercially avail-
able threonine prior to the elimination step9 (Fig. 1).
Herein, we report a mild one-pot method for the synthesis of
a novel dehydrobutyrine-containing amino acid.
2. Results and discussion
Recently we have shown that pentaﬂuoropyridine (3) reacts
with orthogonally protected serine derivatives (e.g., 4 and 5) as
a route to generating novel peptide building blocks (6 and 7)
(Scheme 1).10 As part of this work, it was observed that under
certain reaction conditions, typically an excess of base, dehy-
droalanine derivatives (8 and 9) were also formed as by-products.
The formation of 8 and 9 arises due to abstraction of the acidic a-
H and elimination of the stable 4-(tetraﬂuoropyridine)-oxide
leaving group (10). In an effort to expand and exploit this obser-
vation to access a range of novel dehydrobutyrines potentially
Fig. 1. Dehydroalanine (1) and dehydrobutyrines (2a) and (2b).
q This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
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useful in peptide chemistry, we investigated the reaction between
pentaﬂuoropyridine (3) and various threonine derivatives
(Scheme 2).
The treatment of BoceThreOMe (11) with 3 (2 molar equiv) in
the presence of K2CO3 (3 molar equiv) at room temperature did not
yield any elimination products (Scheme 3).
It was envisaged that the introduction of a more electron-
withdrawing group on the amine, e.g., 4-tetraﬂuoropyridyl rather
than Boc, would make the a-hydrogen more acidic and thereby
promote the desired elimination. As such, under the above condi-
tions, the reaction between mono-protected threonine methyl es-
ter 12 and pentaﬂuoropyridine (3) afforded the single elimination
product 4-(N-tetraﬂuoropyridine)-Dhb-OMe (13) exclusively and
salt 10 (Scheme 4a). 1H NMR analysis of the crude reaction mixture
showed no signals in the a-H region (d 4.00e6.00) and a quartet at
d 6.76e6.85 (J¼7.2 Hz), which was consistent with the formation of
a derivative of 2.7 Puriﬁcation involved an initial ﬁltration step to
remove K2CO3 from the mixture, after which the dehydrobutyrine
13, which was found to be stable on silica, could be easily separated
from the leaving group anion 10 by column chromatography. Ini-
tially, 13 was obtained as a white crystalline solid in a modest 25%
yield. In an attempt to account for the lower than expected re-
covered mass, the ﬁltration step was replaced with partitioning
between CHCl3 and water, affording pure product 13. By modiﬁ-
cation of the work up conditions the isolated yield was consider-
ably improved to 65% and avoided the necessity for column
chromatography.
Replacement of K2CO3 with N,N-diisopropylethylamine (DIPEA),
afforded two products, which were distinguishable by 1H and 19F
NMR analysis of the crude reaction mixture (Scheme 4b). Following
isolation, the products were identiﬁed as N-substituted tetra-
ﬂuoropyridine-L-threonine methyl ester (14, 28%) and dehy-
drobutyrine 13. It therefore appeared that under these conditions
the reaction failed to reach completion and that compound 14,
Scheme 1. Elimination to afford dehydroalanines as a by-product.
Scheme 4. Reaction of L-threonine methyl ester (12) with pentaﬂuoropyridine (3).
Scheme 2. General scheme for conversion of threonine derivatives in to
dehydrobutyrines.
Scheme 3. Reaction of BoceThreOMe (11) with pentaﬂuoropyridine (3).
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arising by substitution on the nitrogen of the threonine prior to the
substitution on the b-hydroxyl group, is an intermediate required
for the transformation into dehydrobutyrine 13. It was considered
that this may be present due to loss of volatile pyridine 3 during the
reaction. Returning to using potassium carbonate as the base, but
this time adding a total of 6 equiv of pyridine 3 in aliquots of
2 equiv/day over 3 days did not improve the conversion to product
13. However, under these reaction conditions the putative in-
termediate 15 was formed. This prompted the suggestion that the
elimination mechanism proceeded via disubstituted threonine
methyl ester intermediate 15; the structure of which was con-
ﬁrmed by X-ray crystallography (Fig. 2). Moreover, the X-ray
structure of intermediate 15 clearly shows that in the crystal form
at least, the a-H and the leaving group have the requisite anti-
periplanar relationship needed to undergo elimination.
The mechanism of the formation of dehydrobutyrine 13 is,
therefore, hypothesised to proceed by sequential substitution re-
actions of pentaﬂuoropyridines; by reaction of ﬁrst the nitrogen
nucleophile to give intermediate 14 and then the b-oxygen nucle-
ophile, affording intermediate 15 followed by elimination
(Scheme 5). Whilst the ﬁrst addition probably occurs rapidly, the
second seems to follow rather more slowly, given the isolation of
intermediate 15, reﬂecting the lower nucleophilicity of O compared
to N and steric effects. The elimination step would be expected to
ensue relatively quickly once the leaving group has been installed,
due to ready deprotonation of the acidic a-hydrogen present in
intermediate 15.11
In order to determine, which geometric isomer (13) was ob-
tained from the elimination reaction a 1H NOESY NMR experiment
was performed. This showed a correlation between the amino
group NH and the b-CH3, whilst no coupling was visible with the b-
H, indicating that only the Z-isomer was formed. Conﬁrmation of
the predicted stereochemistry of dehydrobutyrine 13 was further
provided by single crystal X-ray crystallography, which clearly
shows the Z-conﬁguration of the alkene (Fig. 3).
The mechanism for the formation of the alkene products was
initially predicted to proceed via a concerted E2 elimination of the
alkoxide from the doubly substituted ﬂuoropyridine adduct 15. This
is reported to be the process by which dehydroalanines may be
prepared synthetically.7 However, the additional a-C anion stabil-
ising effects of ﬂanking electron-withdrawing groups in in-
termediate 15, i.e., a methyl ester and a 4-tetraﬂuoropyridylamine
group, not only increases the rate of elimination but may also
serve to favour a possible E1cb mechanism. E1 elimination was
considered to be improbable due to the required formation of
a relatively unstable 2 carbocation at the b-position.
In order to deﬁne the exact mechanism by which elimination
takes place, an experiment involving L-allo-threonine methyl ester
(16) was carried out. Fig. 4 shows that in the case of the E2
mechanism, the geometry of the resulting alkene is inﬂuenced by
the conﬁguration of the starting threonine derivative. Enantiomers,
e.g., L-ThreOMe and D-allo-ThreOMe are expected to give rise to
the same alkene, whereas diastereomers, e.g., L-allo-ThreOMe and
D-ThreOMe should afford the opposite alkene geometry when the
required antiperiplanar arrangement is adopted with respect to
leaving group and the a-H. The result of a concerted E2 elimination
from the N,O-disubstituted adduct would be predicted in the case
of L-allo-ThreOMe to afford the E-alkene as shown by the Newman
projections in Fig. 4.
An elimination reaction was therefore performed on L-allo-
ThreOMe (16) using the same reaction conditions that converted
the diastereomer, L-ThreOMe (12), in to the Z-isomer (13). Three
compounds were isolated from the product mixture: a dehy-
drobuytrine, the N-substituted adduct (17) and the N,O-di-
substituted adduct (18) (Scheme 6). Surprisingly, the only
dehydrobutyrine product obtained was conﬁrmed to be the Z-iso-
mer of dehydrobutyrine 13 by 1H NOESY NMR analysis and X-ray
crystallography. This result ruled out the anticipated E2 elimination
mechanism, which would have generated the E-isomer of dehy-
drobutyrine 13.
The ﬁndings from the elimination reaction involving compound
16 are, however, consistent with the E1cb mechanism shown in
Scheme 7. Removal of the acidic a-H would afford a relatively sta-
bilised carbanion, leading to a mixture of products arising from the
anti-elimination from diastereomers L-allo-Thr and D-allo-Thr if an
E2 elimination mechanism predominated (Fig. 4). Alternatively, the
observed outcome may be explained by resonance stabilisation by
the carbonyl group (well documented for E1cb), which affords
Fig. 2. Structure and X-ray structure of isolated intermediate 15.
Scheme 5. Formation of dehydrobutyrine from L-threonine methyl ester.
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Fig. 3. Molecular structure showing 50% probability anisotropic displacement ellipsoids (left) and crystal packing arrangement (right) of dehydrobutyrine 13.
Fig. 4. Newman projections of the enantiomers and diastereomers of threonine methyl ester in conﬁguration for E2 elimination and the expected stereochemical outcome.
Scheme 6. Reaction of L-allo-threonine methyl ester (16) with pentaﬂuoropyridine (3).
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a planar system about the a-C, whilst free rotation is permitted
about the CaeCb bond. Minimisation of steric interactions between
bulky ﬂuoropyridine groups situates the b-CH3 syn to the NHAr
group and subsequent elimination affords the Z-isomer (Scheme 7).
3. Conclusions
The reaction of pentaﬂuoropyridine with BoceThreOMe (11) in
the presence of a base was not found to generate any elimination
products. However, the reaction of mono-protected threonine
(methyl ester, 12) under the same reaction conditions allowed the
stereo-selective preparation of a novel dehydrobutyrine-containing
amino acid (13). The yield for the formation of dehydrobutyrine 13
could be increased to 65% by simple modiﬁcation of the work up
procedure. The elimination pathway was investigated and the re-
action is proposed to proceed via an E1cb-type mechanism, which
is enabled by the presence of an O-ﬂuoropyridyl leaving group.
Dehydrobutyrine 13 offers a unique opportunity for the dual tag-
ging of peptides (i.e., reaction on the ﬂuoropyridine ring and Mi-
chael addition) and potential applications in this area are currently
under investigation.
4. Experimental
4.1. General
NMR spectra were collected using Bruker Avance 400 MHz,
Varian VNMRS 600 MHz and a Varian VNMRS 700 MHz spec-
trometers. multiplicities; s¼singlet, d¼doublet, dd¼doublet of
doublets, m¼multiplet, t¼triplet, q¼quartet, qd¼quartet of dou-
blets, p¼pentet, br s¼broad singlet. Chemical shifts are reported in
parts per million (ppm) and are referenced to residual solvent
peaks; CHCl3 (1H 7.26 ppm, 13C 77.2 ppm) and DMSO (1H 2.50 ppm,
13C 39.5 ppm). J couplings are measured in hertz (Hz). Reactions
were monitored by TLC using Merck precoated silica gel plates.
Column chromatography was performed using silica gel with the
solvent system indicated. All reported yields refer to the isolated
yield and the product purity was estimated to be >95% by 1H NMR.
IR spectra were recorded on a Perkin Elmer Spectrum RX1 ﬁtted
with an ATR attachment. IR absorptions reported are in cm1. L-allo-
Threonine methyl ester hydrochloride was purchased from
Bachem. All other chemicals were purchased from Sigma Aldrich.
Mass spectra were collected on a Waters TQD mass spectrometer
and accurate mass spectra were collected on a Waters LCT Premier
XE mass spectrometer. Optical rotations were measured with
a Jasco P-1020 polarimeter using CHCl3 as solvent. ortho (o) and
meta (m) are with respect to nitrogen in the ring.
4.2. General procedures
4.2.1. General procedure A: reaction of threonine derivative with
pentaﬂuoropyridine (PFP) in the presence of potassium carbo-
nate. PFP (2 equiv) was added to a stirred suspension of amino acid
starting material (200 mg, 1 equiv), potassium carbonate (3 equiv)
and acetonitrile (8 mL) and left to stir at room temperature for 18 h
and puriﬁed as indicated below.
4.2.1.1. Puriﬁcation procedure A: ﬁltration work up method. The
reaction mixture was ﬁltered and washed with acetonitrile
(210 mL). The ﬁltrate was concentrated in vacuo to afford the
crude product, which was puriﬁed by column chromatography on
silica (20% ethyl acetate, 80% hexane).
4.2.1.2. Puriﬁcation procedure B: extraction work up method.-
Acetonitrile was evaporated from the reaction mixture under re-
duced pressure and the resulting crude mixture was partitioned
between chloroform (15 mL) and water (15 mL). The aqueous layer
was washed twice with chloroform (210 mL) and the combined
organic extracts were dried (MgSO4). Volatiles were removed in
vacuo to give a crude mixture, which was puriﬁed by column
chromatography on silica.
4.3. N-(2,3,5,6-Tetraﬂuoropyridine)-dehydrobutyrine methyl
ester (13)
General reaction procedure A was followed using threonine
methyl ester hydrochloride (12) (200 mg,1.24mmol), PFP (0.27 mL,
2.48 mmol) and potassium carbonate (513 mg, 3.71 mmol).
Scheme 7. Proposed explanation for observed Z-selective alkene formation by E1cb mechanism.
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Puriﬁcation procedure B without the column chromatography step
to give 13 as a white crystalline solid (200 mg, 65%).
Note: According to general procedure A and puriﬁcation pro-
cedure A; employing L-allo-threonine methyl ester (0.20 g,
1.24 mmol), the same product (13) was also obtained as a white
crystalline solid (7 mg, 2%). Mp 107e109 C; nmax/cm1 1481, 1702
(C]O ester), 2922 (CH3), 3325 (NH); [a]D24.0 5.3; dH (600 MHz,
DMSO-d6) 1.84 (3H, d, J 7.2 Hz, CH3), 3.69 (3H, s, OCH3), 6.81 (1H, q, J
7.2 Hz, H-b), 8.87 (1H, s, NH); dF (376 MHz, DMSO-d6) 162.22 (2 F,
m, m-F), 95.94 (2 F, m, o-F); dC (176 MHz, DMSO-d6) 13.5 (CH3),
52.3 (OCH3), 128.8 (C-a), 131.2 (2C, m, C-3), 134.4 (C-b), 137.2 (1C, m,
C-4), 143.5 (2C, m, C-2), 164.0 (COOCH3); HRMS (ESI)
C10H7F4N2O2
 ([MH]); requires 263.0444; found 263.0450.
4.4. N-(2,3,5,6-Tetraﬂuoropyridine)-threonine methyl ester
(14)
PFP (0.27mL, 2.48mmol) was added to a stirred suspension of L-
threonine methyl ester hydrochloride (12) (200 mg, 1.24 mmol),
DIPEA (0.65 mL, 3.72 mmol) and acetonitrile (8 mL) and left to stir
at room temperature overnight. Acetonitrile was removed in vacuo
and the resulting yellow oil was puriﬁed by column chromatogra-
phy on silica (25% ethyl acetate, 75% hexane) to give 14 as a col-
ourless oil (100 mg, 28%). nmax/cm1; 1479, 1648, 1739 (C]O ester),
2981 (CH3), 3400 (br, OH and secondary NH); [a]D24.3 57.4; dH
(400 MHz, CDCl3) 1.38 (3H, d, J 6.0 Hz, CH3), 2.16 (1H, br s, OH), 3.80
(3H, s, OCH3), 4.48e4.53 (2H, m, H-a and H-b), 5.32e5.41 (1H, m,
NH); dF (376 MHz, CDCl3) 162.61 (2F, m,m-F), 93.34 (2F, m, o-F);
dC (176MHz, CDCl3) 20.3 (CH3), 53.1 (OCH3), 61.5 (CeH), 67.8 (CeH),
131.5 (2C, m, C-3), 137.5 (1C, m, C-4), 144.2 (2C, m, C-2), 171.6
(COOCH3); HRMS (ESI) C10H11F4N2O3
þ ([MþH]þ); requires
283.0706; found 283.0710.
4.5. N-(2,3,5,6-Tetraﬂuoropyridine)-threonine-O-(2,3,5,6-
tetraﬂuoropyridine)-methyl ester (15)
PFP (0.27mL, 2.48mmol) was added to a stirred suspension of L-
threoninemethyl ester hydrochloride (12) (200mg,1.24mmol) and
potassium carbonate (513mg, 3.71mmol) in acetonitrile (8mL) and
stirred at room temperature overnight. Additional PFP (0.27 mL,
2.48 mmol) was added to the reaction mixture and stirred for
a further 18 h. A ﬁnal portion of PFP (0.27 mL, 2.48 mmol) was
added to the reaction mixture and left to stir for 18 h. Puriﬁcation
procedure A was followed to give intermediate 15 as a white solid
(37 mg, 7%). Mp 65e66 C; nmax/cm11475, 1641, 1757 (C]O ester),
2975 (CH3), 3315 (secondary NH); [a]D24.4þ7.4; dH (700 MHz, CDCl3)
1.59 (3H, d, J 6.4 Hz, CH3), 3.80 (3H, s, OCH3), 4.77 (1H, dd, J 10.7,
2.2 Hz, H-a), 5.32 (1H, d, J 10.7 Hz, NH), 5.42 (1H, qd, J 6.4, 2.2 Hz, H-
b); dF (564 MHz, CDCl3) 161.93 (2F, m, m-F), 157.16 (2F, m, m-F),
92.37 (2F, m, o-F), 88.79 (2F, m, o-F); dC (151 MHz, CDCl3) 17.4
(CH3), 53.5 (OCH3), 60.7 (CeH), 81.1 (CeH), 132.0 (2C, m, C-3 AreN),
136.1 (2C, m, C-3 AreO), 137.0 (1C, m, C4 AreN), 144.1 (4C, m, C-2
AreO, C-2 AreN), 145.1 (1C, m, C4 AreO), 169.6 (COOCH3); HRMS
(ESI) C15H10F8N3O3
þ ([MþH]þ); requires 432.0594; found
432.0574.
4.6. N-(2,3,5,6-Tetraﬂuoropyridine)-allo-threonine methyl
ester (17) and N-(2,3,5,6-tetraﬂuoropyridine)-allo-L-threo-
nine-O-(2,3,5,6-tetraﬂuoro pyridine)-methyl ester (18)
General reaction procedure Awas followed using L-allo-threonine
methyl ester hydrochloride (16) (200 mg,1.24 mmol), PFP (0.27 mL,
2.48 mmol) and potassium carbonate (513 mg, 3.71 mmol). Puriﬁ-
cation procedure A was followed to give 17 as a colourless oil
(139 mg, 50%). nmax/cm11478, 1648, 1738 (C]O ester), 2959 (CH3),
3386 (br OH and secondary NH); [a]D21.6 14.4; dH (600 MHz, CDCl3)
1.35 (3H, d, J 6.6 Hz, CH3), 2.20 (1H, br s, OH), 3.81 (3H, s, OCH3),
4.20e4.26 (1H, m, H-b), 4.58 (1H, dd, J 9.1, 3.7 Hz, H-a), 5.50 (1H, d, J
9.1 Hz, NH); dF (564 MHz, CDCl3) 162.24 (2F, m, m-F), 93.11 (2F,
m, o-F); dC (151 MHz, CDCl3) 20.0 (CH3), 53.2 (OCH3), 61.6 (CeH),
69.4 (CeH), 131.6 (2C, m, C-3), 136.5 (1C, m, C-4), 144.3 (2C, m, C-2),
170.7 (COOCH3); HRMS (ESIþ) C10H11F4N2O3
þ ([MH]þ); requires
283.0706; found 283.0709.
And 18, as a white solid (49 mg, 9%). Mp 54e55 C; nmax/cm1
1467, 1647, 1726 (C]O ester), 3320 (secondary NH); [a]D24.2 þ36.4;
dH (700 MHz, CDCl3) 1.57 (3H, d, J 6.5 Hz, CH3), 3.92 (3H, s, OCH3),
4.95 (1H, dd, J 8.6, 2.9, H-a), 5.16 (1H, qd, J 6.5, 2.9, H-b), 5.49 (1H, d,
J 8.6, NH); dF (376 MHz, CDCl3) 162.43 (2H, m, m-F), 157.64 (2H,
m, m-F), 92.16 (2H, m, o-F), 88.97 (2H, m, o-F); dC (176 MHz,
CDCl3) 16.5 (CH3), 53.4 (OCH3), 60.2 (C-a), 81.7 (C-b), 131.8 (2C, m,
C-3 AreN), 135.6 (2C, dm, JCF 264 Hz, C-3 AreO), 135.8 (1C, m, C4
AreN), 144.1 (4C, m, C-2 AreO, C-2 Ar-N), 145.4 (1C, m, C4 AreO),
168.3 (COOCH3); HRMS (ESI) C15H8F8N3O3
 ([MH]); requires
430.0438; found 430.0443.
4.7. X-ray crystallography
The X-ray single crystal data have been collected at 120(1) K on
Agilent Gemini S-Ultra (13) and Bruker SMART CCD 6000 (15)
diffractometers equipped with Cryostream (Oxford Cryosystems)
open-ﬂow nitrogen cryostats. Both structures were solved by direct
method and reﬁned by full-matrix least squares on F2 for all data
using Olex212 and SHELXTL13 software. All non-hydrogen atoms
were reﬁned anisotropically, hydrogen atoms in both structures
were located at the difference Fourier maps and reﬁned isotropi-
cally, except those at C(10) methyl group in the structure 15, which
were reﬁned in riding mode. Crystallographic data for the structure
have been deposited with the Cambridge Crystallographic Data
Centre as supplementary publication CCDC-972263e972264.
4.7.1. Crystal data for 13. C10H8F4N2O2, M¼264.18, monoclinic,
space group P21/c, a¼8.5991(4), b¼8.3095(3), c¼15.9343(10) A,
b¼103.386(6), U¼1107.63(10) A3, F(000)¼536.0, Z¼4,
Dc¼1.584 mg m3, m¼0.155 mm1. 12,463 reﬂections, 2673 unique
data (Rmerg¼0.0854). Final wR2(F2)¼0.01251 for all data (195 re-
ﬁned parameters), conventional R1(F)¼0.0527 for 1985 reﬂections
with I2s, GOF¼1.074.
4.7.2. Crystal data for 15. C15H9F8N3O3, M¼431.25, orthorhombic,
space group P21212, a¼9.5212(12), b¼9.6957(12), c¼17.731(2) A,
U¼1636.9(4) A3, F(000)¼864.0, Z¼4, Dc¼1.750 mg m3,
m¼0.182 mm1. 25,278 reﬂections, 3966 unique data
(Rmerg¼0.0669). Final wR2(F2)¼0.1076 for all data (287 reﬁned pa-
rameters), conventional R1(F)¼0.0409 for 2649 reﬂections with
I2s, GOF¼0.990.
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